SVB Wealth LLC Lowers Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• SVB Wealth LLC has reduced its stake in HCA Healthcare, Inc. by 37.4%, owning 2,093 shares valued at $723,000 as of the latest SEC filing.
• HCA Healthcare recently announced quarterly earnings, reporting $6.84 EPS, exceeding expectations and marking a 6.4% increase in year-over-year revenue.
• Research analysts have given mixed ratings for HCA Healthcare, with an average rating of "Moderate Buy" and an average target price of $398.58.

SVB Wealth LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 37.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,093 shares of the company's stock after selling 1,249 shares during the period. SVB Wealth LLC's holdings in HCA Healthcare were worth $723,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of HCA. Brighton Jones LLC acquired a new position in HCA Healthcare in the fourth quarter valued at approximately $1,021,000. Hancock Whitney Corp grew its position in HCA Healthcare by 24.8% during the fourth quarter. Hancock Whitney Corp now owns 5,130 shares of the company's stock valued at $1,540,000 after buying an additional 1,019 shares during the period. Coldstream Capital Management Inc. boosted its stake in shares of HCA Healthcare by 1.3% during the 4th quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company's stock worth $1,042,000 after acquiring an additional 44 shares in the last quarter. Boothbay Fund Management LLC purchased a new position in shares of HCA Healthcare in the 4th quarter valued at about $786,000. Finally, Oxford Asset Management LLP purchased a new position in HCA Healthcare during the fourth quarter worth approximately $879,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on HCA. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Cantor Fitzgerald reissued an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday. Royal Bank Of Canada lowered their price objective on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. JPMorgan Chase & Co. raised their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Finally, Truist Financial increased their price objective on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $401.83.

HCA Healthcare Trading Down 0.3%

HCA Healthcare stock traded down $1.05 during trading on Tuesday, reaching $401.72. 1,180,566 shares of the company were exchanged, compared to its average volume of 1,273,427. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a market capitalization of $94.00 billion, a P/E ratio of 16.89, a PEG ratio of 1.27 and a beta of 1.39. The stock's 50 day simple moving average is $375.19 and its two-hundred day simple moving average is $355.12. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the previous year, the company posted $5.50 EPS. The company's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.